Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”

Detalles Bibliográficos
Autor principal: Namour, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661215/
https://www.ncbi.nlm.nih.gov/pubmed/26482170
http://dx.doi.org/10.1007/s40262-015-0336-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661215/
https://www.ncbi.nlm.nih.gov/pubmed/26482170
http://dx.doi.org/10.1007/s40262-015-0336-5

Ejemplares similares